Back

Common genetic variations in telomere length genes and lung cancer

Penha, R. C. C.; Smith-Byrne, K.; Atkins, J. R.; Haycock, P.; Kar, S.; Codd, V.; Samani, N. J.; Nelson, C. P.; Milojevic, M.; Gabriel, A. A.; Amos, C.; Brennan, P.; Hung, R. J.; Kachuri, L.; McKay, J. D.

2022-08-24 genetic and genomic medicine
10.1101/2022.08.24.22279131 medRxiv
Show abstract

BackgroundGenome-wide association studies (GWAS) have identified genetic susceptibility variants for both leukocyte telomere length (LTL) and lung cancer susceptibility. Recently, 108 novel genetic loci within genes involved in telomere biology and DNA repair have been linked to LTL in UK Biobank. In the current work, we investigated the relationship between genetically predicted LTL and lung cancer. MethodsTo explore the shared genetic basis between LTL and lung cancer, we performed genetic correlation, Mendelian Randomization (MR), and colocalisation analyses using the largest available GWASs of LTL (N=464,716) and lung cancer (29,239 cases; 56,450 controls). To further characterize the molecular mechanisms underlying this relationship, principal component analysis (PCA) was used to summarize gene expression profiles in lung adenocarcinoma tumours from The Cancer Genome Atlas. ResultsAlthough there was no genome-wide genetic correlation between LTL and lung cancer risk (rg=-0.01, p=0.88), MR analyses using 144 instruments identified a putatively causal association. Longer LTL conferred an increased risk of lung cancer (OR=1.62, 95%CI=1.44-1.83, p=9.9x10-15), lung cancer in never smokers (OR=2.02, 95%CI=1.45-2.83, p=3.78x10-05), and lung adenocarcinoma (OR=2.43, 95%CI=2.02-2.92, p=3.8x10-21). Of these 144 LTL genetic instruments, 12 showed evidence of colocalisation with lung adenocarcinoma risk and revealed novel susceptibility loci, including MPHOSPH6 (rs2303262), PRPF6 (rs80150989), and POLI (rs2276182). A polygenic risk score for LTL was associated with the second principal component (PC2) of gene expression (Beta=0.17, p=1.0x10-3). The aspect of PC2 associated with longer LTL was also associated with being female (p=0.005), never smokers (p=0.04), and earlier tumour stage (p=0.002). PC2 was strongly associated with cell proliferation score (p=3.6x10-30) and genomic features related to genome stability, including copy number changes (p=1.6x10-5) and telomerase activity (p=1.3x10-5) in the multivariate regression analyses. ConclusionsThis study identified an association between longer genetically predicted LTL and lung cancer and sheds light on the potential molecular mechanisms related to LTL in lung adenocarcinomas.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Human Molecular Genetics
130 papers in training set
Top 0.1%
10.4%
2
Molecular Oncology
50 papers in training set
Top 0.1%
10.1%
3
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.1%
6.3%
4
European Respiratory Journal
54 papers in training set
Top 0.3%
4.8%
5
Scientific Reports
3102 papers in training set
Top 31%
4.0%
6
Clinical Epigenetics
53 papers in training set
Top 0.3%
3.6%
7
Genome Medicine
154 papers in training set
Top 2%
3.6%
8
Genes
126 papers in training set
Top 0.4%
3.1%
9
PLOS ONE
4510 papers in training set
Top 42%
3.1%
10
ERJ Open Research
44 papers in training set
Top 0.3%
2.4%
50% of probability mass above
11
Nature Communications
4913 papers in training set
Top 47%
2.1%
12
Frontiers in Oncology
95 papers in training set
Top 2%
1.9%
13
Cell & Bioscience
14 papers in training set
Top 0.1%
1.9%
14
EBioMedicine
39 papers in training set
Top 0.4%
1.7%
15
European Journal of Human Genetics
49 papers in training set
Top 0.6%
1.7%
16
Cancers
200 papers in training set
Top 3%
1.7%
17
Aging Cell
144 papers in training set
Top 2%
1.3%
18
BMC Medicine
163 papers in training set
Top 4%
1.3%
19
International Journal of Cancer
42 papers in training set
Top 0.8%
1.3%
20
npj Genomic Medicine
33 papers in training set
Top 0.5%
1.3%
21
BMC Genomics
328 papers in training set
Top 4%
1.2%
22
Genomics
60 papers in training set
Top 2%
1.2%
23
Frontiers in Immunology
586 papers in training set
Top 6%
0.9%
24
Journal of Translational Medicine
46 papers in training set
Top 2%
0.9%
25
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.7%
0.9%
26
Epigenetics
43 papers in training set
Top 0.8%
0.9%
27
Annals of Oncology
13 papers in training set
Top 0.9%
0.8%
28
PLOS Genetics
756 papers in training set
Top 14%
0.8%
29
The American Journal of Human Genetics
206 papers in training set
Top 3%
0.8%
30
Translational Oncology
18 papers in training set
Top 0.3%
0.8%